An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress
Mohammad Shokrzadeh, Mahmoud Etebari, Nasrin Ghassemi-Barghi
Topics & Concepts
Oxidative stressPharmacologyGenotoxicityMicronucleus testApoptosisDoxorubicinDNA damageChemistryComet assayInflammationCytotoxicityToxicityBiologyImmunologyBiochemistryIn vitroChemotherapyDNAOrganic chemistryGeneticsChemotherapy-induced cardiotoxicity and mitigationChemotherapy-induced organ toxicity mitigationPARP inhibition in cancer therapy